Aspen Aerogels (NYSE: ASPN) reported Q2 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $24.6 million versus the consensus estimate of $23.04 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.